Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medications.

Détails

Ressource 1Télécharger: BIB_196A04D0B560.P001.pdf (244.75 [Ko])
Etat: Public
Version: de l'auteur
ID Serval
serval:BIB_196A04D0B560
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medications.
Périodique
Plos One
Auteur(s)
Auer R., Gencer B., Räber L., Klingenberg R., Carballo S., Carballo D., Nanchen D., Cornuz J., Vader J.P., Vogt P., Jüni P., Matter C.M., Windecker S., Lüscher T.F., Mach F., Rodondi N.
ISSN
1932-6203 (Electronic)
ISSN-L
1932-6203
Statut éditorial
Publié
Date de publication
2014
Peer-reviewed
Oui
Volume
9
Numéro
3
Pages
e93147
Langue
anglais
Notes
Publication types: Journal Article Publication Status: epublish
Résumé
BACKGROUND: Adherence to guidelines is associated with improved outcomes of patients with acute coronary syndrome (ACS). Clinical registries developed to assess quality of care at discharge often do not collect the reasons for non-prescription for proven efficacious preventive medication in Continental Europe. In a prospective cohort of patients hospitalized for an ACS, we aimed at measuring the rate of recommended treatment at discharge, using pre-specified quality indicators recommended in cardiologic guidelines and including systematic collection of reasons for non-prescription for preventive medications.
METHODS: In a prospective cohort with 1260 patients hospitalized for ACS, we measured the rate of recommended treatment at discharge in 4 academic centers in Switzerland. Performance measures for medication at discharge were pre-specified according to guidelines, systematically collected for all patients and included in a centralized database.
RESULTS: Six hundred and eighty eight patients(54.6%) were discharged with a main diagnosis of STEMI, 491(39%) of NSTEMI and 81(6.4%) of unstable angina. Mean age was 64 years and 21.3% were women. 94.6% were prescribed angiotensin converting enzyme i